Online Inquiry
Cat.#: ACPP-1846
| Despition | FGF 9 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% by RP-HPLC and SDS-PAGE. |
| Form | Sterile Filtered white lyophilized powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1702 | Human PCSK1N Protein (AC1702) | 2 µg | inquiry |
| ACPP-1297 | p75 NGF Receptor Blocking Peptide (AC1297) | 250 µg | inquiry |
| ACPP-1359 | iNOS Blocking Peptide (AC1359) | 250 µg | inquiry |
| ACPP-1583 | Human NRTN Protein (AC1583) | 5 µg | inquiry |
| ACPP-1203 | ADCY8 Blocking Peptide (AC1203) | 250 µg | inquiry |
| ACPP-1255 | MC3 Receptor Blocking Peptide (AC1255) | 250 µg | inquiry |
| ACPP-1232 | GPCR GPR15 Blocking Peptide (AC1232) | 250 µg | inquiry |
| ACPP-1090 | PAX5 Blocking Peptide (AC1090) | 250 µg | inquiry |
| ACPP-1658 | Human Acrp30 Protein, His (AC1658) | 10 µg | inquiry |
| ACPP-1417 | Human STMN3 Protein (AC1417) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.